Convalescent Plasma Administration Worsens Respiratory Failure in Hospitalized Seronegative COVID 19 Patients
Sonal Pannu(Oklahoma City University), Jeffrey C. Horowitz(Lung Institute), Rama K. Mallampalli(The Ohio State University), Scott Scrape(The Ohio State University), Michael H. Cardone(The Ohio State University), M. Doraiswamy(Smith Clinic), Gerard Lozanski(The Ohio State University), Matthew C. Exline(The Ohio State University), Sijun Liu(The Ohio State University)
Cited by 0
Related Papers
Extracellular matrix in lung development, homeostasis and disease
|Matrix Biology|2018|290
Enhanced neutralization resistance of SARS-CoV-2 Omicron subvariants BQ.1, BQ.1.1, BA.4.6, BF.7, and BA.2.75.2
|Cell Host & Microbe|2022|280
Future Directions in Idiopathic Pulmonary Fibrosis Research. An NHLBI Workshop Report
|American Journal of Respiratory and Critical Care Medicine|2013|247
Activation of the Pro-survival Phosphatidylinositol 3-Kinase/AKT Pathway by Transforming Growth Factor-β1 in Mesenchymal Cells Is Mediated by p38 MAPK-dependent Induction of an Autocrine Growth Factor
|Journal of Biological Chemistry|2004|229
Neutralization of the SARS-CoV-2 Omicron BA.4/5 and BA.2.12.1 Subvariants
|New England Journal of Medicine|2022|181